 CollPlant NASDAQ: CLGN, a regenerative and aesthetics medicine company, today announced financial results for the first quarter ended March 31, 2020 and provided an update on the Companys business developments. Certain metrics, including those expressed on an adjusted basis, are non-GAAP measures. See Use of Non-GAAP Measures below. 